ABSTRACT
The broad objective of the Administrative Core is to provide infrastructure for the effective operation of the
Heteroresistance Interdisciplinary Research Unit (HR-IRU) by facilitating synergistic and productive interactions
amongst the investigators. The Administrative Core (Core A) is essential to help the HR-IRU efficiently meet its
long-term goal of understanding the mechanistic bases, dynamics, and prevalence of heteroresistance. The
activities of the Core will be led by Drs. David Weiss and Bruce Levin supported by Ms. Dianne Miller and Ms.
Pearl Backman. The goals of Core A are defined by five specific aims, along with Staffing and Management
Plans. The aims will be achieved by providing a defined structure for operational logistics between the institutions
and research groups in the Unit. The HR-IRU is comprised of an international team of investigators with a strong
history of productive collaboration, and will facilitate the continued communication and synergistic interactions
among the investigators in the research projects and cores. Core A will implement and oversee regular
videoconferences, face-to-face meetings, and annual meetings. Structures have been developed for conflict
resolution, scientific oversight, and communication logistics to ensure effective operation of the HR-IRU.
Management, coordination, and finances of the HR-IRU will operate seamlessly between the administrative
offices and research groups at Emory University and the University of Uppsala. Plans are in place to protect the
intellectual property rights of the HR-IRU investigators by managing data sharing agreements and interactions
internally and externally to the HR-IRU. A framework is in place for regular communication and transparency
between the HR-IRU and the NIH/NIAID program staff, and responsiveness to requests from the NIH/NIAID.
The HR-IRU also aims to broaden the heteroresistance research community by identifying and seeking potential
collaborations between HR-IRU investigators and external researchers studying related or relevant phenomena.
This includes broad communications within Emory University and University of Uppsala communities, outreach
to researchers through presentation of findings at meetings and conferences, and invitation of an external
scientific expert to participating the Unit's annual meetings. The processes implemented by the Administrative
Core and outlined by these five aims build upon existing collaborations to coordinate the smooth operation of
the highly interdisciplinary Unit and interactions broader community, in order to be successful in making
fundamental gains in our understanding of heteroresistance.
Public Health Relevance Statement
PROJECT NARRATIVE
In accordance with RFA-AI-20-001, the project narrative should not be completed for the Administrative Core.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AgreementAntibiotic ResistanceAwarenessCollaborationsCommunicationCommunitiesEnsureGoalsInfrastructureInstitutionIntellectual PropertyInterdisciplinary StudyIntermediate resistanceInternationalLogisticsNational Institute of Allergy and Infectious DiseasePrevalenceProcessProductivityProperty RightsRecording of previous eventsResearchResearch PersonnelResearch Project GrantsStructureU-Series Cooperative AgreementsUnited States National Institutes of HealthUniversitiesbaseconflict resolutiondata managementdata sharingdesignmaterial transfer agreementmeetingsoperationoutreachprogramssymposiumvideoconference
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
066469933
UEI
S352L5PJLMP8
Project Start Date
05-March-2021
Project End Date
28-February-2026
Budget Start Date
01-March-2024
Budget End Date
28-February-2025
Project Funding Information for 2024
Total Funding
$120,972
Direct Costs
$71,751
Indirect Costs
$49,221
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$120,972
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U19AI158080-04 5644
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U19AI158080-04 5644
Patents
No Patents information available for 5U19AI158080-04 5644
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U19AI158080-04 5644
Clinical Studies
No Clinical Studies information available for 5U19AI158080-04 5644
News and More
Related News Releases
No news release information available for 5U19AI158080-04 5644
History
No Historical information available for 5U19AI158080-04 5644
Similar Projects
No Similar Projects information available for 5U19AI158080-04 5644